Gasket
US-2018266565-A1 · Sep 20, 2018 · US
US9718904B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9718904-B2 |
| Application number | US-201313851608-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2013 |
| Priority date | Feb 19, 2013 |
| Publication date | Aug 1, 2017 |
| Grant date | Aug 1, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A microdroplet or microparticle with Janus or core-shell internal morphology, which is obtained under the control of phase separation of high-concentration NIPAAm formed at 25° C. or more in a microfluidic device, is provided. The microdroplet or microparticle shows an anisotropic volume change according to a change in temperature, and can also serve as a fat-soluble/water-soluble carrier, and thus can be used as a new material for medical supplies in the field of various applications in the future.
Opening claim text (preview).
What is claimed is: 1. A microdroplet consisting of H-phase N-isopropylacrylamide (NIPAAm) and L-phase NIPAAm, wherein the H-phase NIPAAm and the L-phase NIPAAm are prepared using phase separation of a single component aqueous solution consisting of NIPAAm and water, the microdroplet has a single clear boundary between phases, and the microdroplet has Janus morphology or core-shell internal morphology. 2. The microdroplet according to claim 1 , wherein the H-phase NIPAAm and the L-phase NIPAAm are obtained by dissolving in water the NIPAAm at 25° C. or more at a molar concentration 10 times higher than that of water and performing phase separation of the NIPAAm. 3. The microdroplet according to claim 1 , wherein the Janus morphology is obtained by injecting a mineral oil into a microfluidic device, and the core-shell internal morphology is obtained by injecting a silicone oil into a microfluidic device. 4. The microdroplet according to claim 1 , wherein the microdroplet is prepared by injecting a H-phase NIPAAm and a L-phase NIPAAm in range of a volume ratio 1:3 to 3:1 as dispersed phases and oil as a continuous phase to a microfluidic device. 5. The microdroplet according to claim 1 , wherein the microdroplet shows fat-solubility and water-solubility carrier characteristics. 6. A microparticle obtained by curing the microdroplet of claim 1 . 7. The microparticle according to claim 6 , wherein the microparticle is obtained by adding a cross linker and a photoinitiator to the microdroplet. 8. The microparticle of claim 7 , wherein the cross linker is N,N′-methylenebisacrylamide (MBAAm), and the photo initiator is 2-hydroxy-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone. 9. The microparticle according to claim 6 , wherein the microparticle shows fat-solubility and water-solubility carrier characteristics. 10. The microparticle according to claim 6 , wherein the microparticle shows an anisotropic volume change depending on a change in temperature ranging from 24° C. to 36° C.
Amides {, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide} · CPC title
Acrylamide; Methacrylamide · CPC title
Acrylamide; Methacrylamide · CPC title
Acrylamide; Methacrylamide · CPC title
Amides {, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.